TXNL4A and hepatocellular carcinoma: The relationship between TXNL4A and HCC with regard to OS and progression-free interval (PFI) was analyzed using log-rank tests, and all survival analyses revealed that patients with high HCC expression exhibited worse survival than those with low HCC expression (Figures 4A, B) (OS: p < 0.001; PFI: p = 0.002).